# A Trial Investigating the Relationship Between Pharmacodynamic and Interstitial Concentration for Insulin Detemir and Human Insulin

> **NCT02162407** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 13 (actual)

## Conditions studied

- Diabetes
- Healthy

## Interventions

- **DRUG:** insulin detemir
- **DRUG:** human soluble insulin

## Key facts

- **NCT ID:** NCT02162407
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10
- **Primary completion:** 1999-12
- **Final completion:** 1999-12
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2014-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02162407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02162407, "A Trial Investigating the Relationship Between Pharmacodynamic and Interstitial Concentration for Insulin Detemir and Human Insulin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02162407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*